Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (81-90 of 339) with videos related to

Pageof 34
Sort By:
Breast Cancer Research and Treatment|September 1, 2006
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancerDavid Cella, Lesley Fallowfield, Peter Barker, et al.
Biomedical Physics & Engineering Express|September 3, 2025
Mammographic density assessed using deep learning in women at high risk of developing breast cancer: the effect of weight change on densitySteven Squires, Michelle Harvie, Anthony Howell, et al.
BMC Women'S Health|November 12, 2022
Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancerMary Pegington, Elaine F Harkness, Anthony Howell, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2012
Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body productionAhmed F Salem, Anthony Howell, Marina Sartini, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Response and resistance to the endocrine prevention of breast cancerAnthony Howell, Nigel J Bundred, Jack Cuzick, et al.
The Breast Journal|September 9, 2006
Predicting compliance in a breast cancer prevention trialAndrew Maurice, Anthony Howell, D Gareth Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialLesley Fallowfield, David Cella, Jack Cuzick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialIvana Sestak, Wolfgang Distler, John F Forbes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogenRognvald N Blance, Andrew H Sims, Elizabeth Anderson, et al.
British Journal of Health Psychology|July 3, 2023
How do women at increased risk of breast cancer make sense of their risk? An interpretative phenomenological analysisVictoria G Woof, Lorna McWilliams, Anthony Howell, et al.
Pageof 34

Showing results (81-90 of 339) with videos related to

Sort By:
Pageof 34
Breast Cancer Research and Treatment|September 1, 2006
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancerDavid Cella, Lesley Fallowfield, Peter Barker, et al.
Biomedical Physics & Engineering Express|September 3, 2025
Mammographic density assessed using deep learning in women at high risk of developing breast cancer: the effect of weight change on densitySteven Squires, Michelle Harvie, Anthony Howell, et al.
BMC Women'S Health|November 12, 2022
Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancerMary Pegington, Elaine F Harkness, Anthony Howell, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2012
Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body productionAhmed F Salem, Anthony Howell, Marina Sartini, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Response and resistance to the endocrine prevention of breast cancerAnthony Howell, Nigel J Bundred, Jack Cuzick, et al.
The Breast Journal|September 9, 2006
Predicting compliance in a breast cancer prevention trialAndrew Maurice, Anthony Howell, D Gareth Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialLesley Fallowfield, David Cella, Jack Cuzick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialIvana Sestak, Wolfgang Distler, John F Forbes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogenRognvald N Blance, Andrew H Sims, Elizabeth Anderson, et al.
British Journal of Health Psychology|July 3, 2023
How do women at increased risk of breast cancer make sense of their risk? An interpretative phenomenological analysisVictoria G Woof, Lorna McWilliams, Anthony Howell, et al.
Pageof 34